Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
Starting soon
Conditions studied: Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema), Atopic Dermatitis Patients, Atopic Dermatitis / Eczema, Atopic Dermatitis, Unspecified
In brief
The goal of this observational registry is to characterize the clinical features, severity, treatments, and outcomes of patients with atopic dermatitis in Costa Rica receiving systemic and advanced therapies in routine clinical practice. The main questions it aims to answer are: What are the demographic and clinical characteristics of patients with moderate-to-severe atopic dermatitis treated in specialized dermatology centers in Costa Rica? What treatments are used in real-world practice and how do they impact disease severity and patient-reported outcomes over time? Participants with atopic dermatitis receiving systemic or advanced therapies as part of their usual medical care will be followed longitudinally, with collection of clinical severity scores, treatment patterns, and outcomes during routine visits.
Key facts
- Study ID
- NCT07448363
- Run by
- Caja Costarricense de Seguro Social
- People needed
- 50
- Starts
- 2026-05-01
- Expected to finish
- 2031-05-01
- Last updated by the study team
- 2026-04-08
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Clinical diagnosis of atopic dermatitis according to accepted diagnostic criteria
- Moderate-to-severe disease requiring systemic or advanced therapy
- Receiving systemic immunosuppressive, biologic, or other advanced treatment as part of routine care
- Evaluated in participating dermatology centers in Costa Rica
- Available clinical records with baseline and follow-up information
You may not qualify if…
- Lack of sufficient clinical data for severity or treatment assessment
Where it is running
- Caja Costarricense del Seguro Social — San José, Provincia de San José, Costa Rica
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.